Share chart Personalis, Inc.
Extended chart
Simple chart
About Personalis, Inc.
Personalis, Inc. работает по всему миру как компания, занимающаяся геномикой рака. Компания предоставляет услуги секвенирования и анализа данных для поддержки разработки методов лечения рака и крупномасштабных программ генетических исследований. more details| IPO date | 2019-06-20 |
|---|---|
| ISIN | US71535D1063 |
| Industry | Life Sciences Tools & Services |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.personalis.com |
| Цена ао | 3.42 |
| Change price per day: | 0% (3.42) |
|---|---|
| Change price per week: | -5.26% (3.61) |
| Change price per month: | -19.15% (4.23) |
| Change price per 3 month: | -45.37% (6.26) |
| Change price per half year: | -34.48% (5.22) |
| Change price per year: | +129.53% (1.49) |
| Change price per 3 year: | -58.5% (8.24) |
| Change price per 5 year: | -58.34% (8.21) |
| Change price per year to date: | -42.71% (5.97) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| ARK Investment Management, LLC | 5736163 | 11.82 |
| JP Morgan Chase & Company | 3627721 | 7.48 |
| Blackrock Inc. | 3410815 | 7.03 |
| Vanguard Group Inc | 2065601 | 4.26 |
| Alyeska Investment Group, L.P. | 1245668 | 2.57 |
| Sumitomo Mitsui Trust Holdings, Inc. | 1083685 | 2.23 |
| Nikko Asset Management Americas, Inc. | 1018713 | 2.1 |
| Wellington Shields & Co., LLC | 1013313 | 2.09 |
| Balyasny Asset Management LLC | 1004610 | 2.07 |
| Wellington Shields Capital Management, Llc | 882938 | 1.82 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| ARK Genomic Revolution ETF | 2.85667 | -8.08 | 0.05494 |
| iShares Micro-Cap ETF | 0.05095 | 17.09 | 1.54048 |
| Avantis U.S Small Cap Equity ETF | 0.0085 | 27.77 | 1.68271 |
| Dimensional U.S. Equity ETF | 0.00012 | 31.53 | 1.3557 |
| Dimensional US Core Equity Market ETF | 0.00011 | 30.98 | 1.40618 |
| 0.58 | 19.86 | 1.21 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Christopher M. Hall | President, CEO & Director | 506.39k | 1969 (56 years) |
| Mr. Aaron L. Tachibana | CFO & COO | 569.6k | 1961 (64 years) |
| Dr. Russ B. Altman M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | N/A | |
| Dr. Euan A. Ashley DPHIL, FRCP, M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | N/A | 1971 (54 years) |
| Mr. Stephen M. Moore J.D. | Senior VP & Chief Legal Officer | N/A | 1972 (53 years) |
| Mr. Michael J Fitzpatrick | Vice President of Worldwide Sales | N/A | |
| Dr. Richard Chen M.D., M.S. | Executive VP of R&D and Chief Medical Officer | 584.17k | 1971 (54 years) |
| Dr. Michael P. Snyder Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | N/A | |
| Dr. Christian Haudenschild Ph.D. | Senior Vice President of Genomic Laboratory Operations | N/A | |
| Mr. Stephane Mouradian Ph.D. | Senior Vice President of Business Development | N/A |
Address: United States, Fremont. CA, 6600 Dumbarton Circle - open in Google maps, open in Yandex maps
Website: https://www.personalis.com
Website: https://www.personalis.com
